United Therapeutics (UTHR) Assets (2016 - 2025)
Historic Assets for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $7.4 billion.
- United Therapeutics' Assets rose 320.09% to $7.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 billion, marking a year-over-year increase of 320.09%. This contributed to the annual value of $7.4 billion for FY2024, which is 274.87% up from last year.
- According to the latest figures from Q3 2025, United Therapeutics' Assets is $7.4 billion, which was up 320.09% from $7.9 billion recorded in Q2 2025.
- United Therapeutics' 5-year Assets high stood at $7.9 billion for Q2 2025, and its period low was $4.6 billion during Q1 2021.
- In the last 5 years, United Therapeutics' Assets had a median value of $6.5 billion in 2024 and averaged $6.3 billion.
- Its Assets has fluctuated over the past 5 years, first surged by 2148.19% in 2023, then skyrocketed by 62.71% in 2024.
- Over the past 5 years, United Therapeutics' Assets (Quarter) stood at $5.2 billion in 2021, then rose by 16.94% to $6.0 billion in 2022, then increased by 18.57% to $7.2 billion in 2023, then increased by 2.75% to $7.4 billion in 2024, then decreased by 0.18% to $7.4 billion in 2025.
- Its last three reported values are $7.4 billion in Q3 2025, $7.9 billion for Q2 2025, and $7.7 billion during Q1 2025.